Kestra Medical Technologies announced today that it appointed Al Ford as its new chief commercial officer (CCO).

Kestra Medical recently filed a form S-1 to confirm its intent to go public through an initial public offering (IPO).

Kestra Medical Technologies, Ltd. targets growth in the cardiac defibrillator market with an IPO, despite operating losses.

Be (not too) still my heart: Kestra Medical Technologies Ltd., maker of a wearable cardioverter defibrillator for patients at high risk of cardiac arrest, filed an S-1 with the U.S. SEC on Feb. 9 to ...

Kestra launched in 2014 and makes wearable devices to detect and respond ... a company that sold external defibrillators and was acquired by Stryker for $1.28 billion in 2016.

Kestra will join what’s been a strong start to the year for U.S. healthcare IPOs with seven companies raising $1.1 billion ...

Ltd. (“Kestra”), a wearable medical device and digital healthcare company, announced today that Al Ford is joining the company ...

Kestra Medical Technologies Ltd. has filed for an initial public offering, showing revenue growth that nearly tripled. The maker of wearable medical devices is offering new shares in the IPO ...

Kestra Medical Technologies (KMTS), a developer of wearable medical devices, has filed for a proposed $100M initial public offering. The company didn't state any terms in its SEC filing, but did ...

The maker of wearable medical devices is offering new ... according to the filing. Kestra raised $196 million in a July round co-led by Andera Partners, Ally Bridge Group, Longitude Capital ...